Sabaa International Company for Pharmaceutical and Chemical Industry (CASE: SIPC)
Health Care · Pharmaceuticals · EG
EGP4.73
+1.07% today · +2.8% 1Y
Sabaa International Company for Pharmaceutical and Chemical Industry (CASE: SIPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $23.24M.
Over the last twelve months the share price has gained 2.8%, trading between 2.62 and 5.50.
Tweenvest scores Sabaa International Company for Pharmaceutical and Chemical Industry across four factors: quality 62/100, value 15/100, growth 62/100. Its strongest factor is quality.
SIPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.24M
- Revenue (TTM)
- $851.97K
- P/E
- —
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- EGP5.50
- 52-week low
- EGP2.62
- Avg volume (3M)
- —
- Shares outstanding
- 250.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.